How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis

How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis

Monoclonal antibodies targeting epidermal growth factor receptor (EGFR) or vascular endothelial growth factor (VEGF) have demonstrated efficacy with chemotherapy (CT) as second line treatment for metastatic colorectal cancer (mCRC). The right sequence of the treatments in all RAS (KRAS/NRAS) wild ty...

Full description

Bibliographic Details
Main Authors: Antonio Galvano, Lorena Incorvaia, Giuseppe Badalamenti, Sergio Rizzo, Aurelia Guarini, Stefania Cusenza, Luisa Castellana, Nadia Barraco, Valentina Calò, Sofia Cutaia, Giuseppe Currò, Nicola Silvestris, Giordano Domenico Beretta, Viviana Bazan, Antonio Russo
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
meta-analysis
colorectal cancer
second line
targeted agents
sequence
VEGF
EGFR
Online Access:https://www.mdpi.com/2072-6694/11/8/1189

Internet

https://www.mdpi.com/2072-6694/11/8/1189

Similar Items